Location: Home
  • search
  • go
  • Relate News
  • 6/4/2024HuidaGene and Synthego Announce Licensing Deal on Next-Generation Gene...
  • 6/4/2024Central Government Issues New Document to Promote Decentralization of ...
  • 6/4/2024Genscript Denies Party Links
  • 6/4/2024China Biotech Podcast: Going Global Trends, Rare Disease Drug Developm...
  • 6/3/2024Western Companies Drive Chinese Biotech Licensing Deal Blitz (FT)
  • 6/3/2024Fosun Reportedly Weighing Buyout of Henlius Biotech: Bloomberg
  • 6/3/2024Emerging and Chinese Pharma Cos Take Greater Role in Oncology Drug Dev...
  • 6/3/2024Sales Expenditures of Chinese Pharma Cos Continued to Grow But Lagging...
  • 6/3/2024Review of Chinese Retail Pharmacy Market (Offline and Online) in 2023
  • 6/3/2024NHSA Issues the Procedures for Classification Determination in the NRD...
  • 6/3/2024CDE Solicits Comments on the Guidelines for Evaluating the Pharmacokin...
  • 5/31/2024Summit Falls amid Concerns over 'China-Only' Trial Data Outperforming ...
  • 5/31/2024NH's DB6: China's Consumer Healthcare Market Underperformed in 2023
  • 5/31/2024NH's DB6: Top Ten Chinese CHC Brands in 2023
  • 5/31/2024NH's DB6: Chinese OTC Drug Market Forecast 2028/2033
  • 5/31/2024China Has Approved 21 Children's Medicines in 2024
  • 5/31/2024CDE Solicits Comments on the Technical Guidelines for the Analysis and...
  • 5/31/2024Drug R&D and Product Registration News Digest May 2024 (4)
  • 5/31/2024U.S. Congress Seeks FBI Briefing on GenScript Over Potential Chinese I...
  • 5/31/2024Recent Executive Moves
  • 5/31/2024Manufacturing Inspections Down in China amid Arrest Fears and No Acces...
  • 5/31/2024Building Resilient Supply Chains in the Face of Tightening Chinese Ant...
  • 5/30/2024U.S. Rethinks Timing of Biotech Crackdown, Easing Pressure on WuXi Fam...
  • 5/30/2024CDE Issues the Technical Guidelines for Application of Decentralized C...
  • 5/30/2024NHC Publicizes the List of Pediatric Drugs Encouraged for R&D and Regi...
  • 5/29/2024Bio-Thera and STADA Enter Exclusive Deal for BGolimumab Biosimilar in ...
  • 5/29/2024SGD Pharma Invests €20M in Chinese Facility
  • 5/29/2024Caixin Explains: How China Is Overhauling Regulations on Genetic Resou...
  • 5/28/2024Rapid Expansion in China Drives Growth in Global Cancer Clinical Trial...
  • 5/28/2024NMPA Holds Meeting to Review Vaccine Regulatory QMS
  • Page:91/803 Total number of articles:24085: [First][<<] [89] [90] [91] [92] [93] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group